beta blocker: increase blood sugar

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
increase blood sugar 1.00
lower blood sugar 0.95
decrease blood pressure 0.85
reduce blood pressure 0.82
lower blood pressure 0.80
increase potassium 0.80
become low blood pressure 0.78
cause high blood pressure 0.78
affect oxygen uptake by blood 0.78
be used for high blood pressure 0.78

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.47
Rule weight: 0.66
Evidence weight: 0.90
Similarity weight: 0.78
Evidence: 0.77
Plausible(heart disease, cause high blood pressure)
Evidence: 0.43
¬ Typical(beta blocker, increase blood sugar)
0.35
Rule weight: 0.66
Evidence weight: 0.68
Similarity weight: 0.78
Evidence: 0.25
Plausible(high blood pressure, become low blood pressure)
Evidence: 0.43
¬ Typical(beta blocker, increase blood sugar)

Plausibility inheritance from parent to child

0.06
Rule weight: 0.09
Evidence weight: 0.82
Similarity weight: 0.78
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.25
¬ Plausible(high blood pressure, become low blood pressure)
0.03
Rule weight: 0.09
Evidence weight: 0.45
Similarity weight: 0.78
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.77
¬ Plausible(heart disease, cause high blood pressure)

Remarkability exclusitivity betweem a parent and a child

0.38
Rule weight: 0.58
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.51
¬ Remarkable(heart disease, cause high blood pressure)
0.32
Rule weight: 0.58
Evidence weight: 0.70
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.94
¬ Remarkable(high blood pressure, become low blood pressure)

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.86
¬ Remarkable(cystic fibrosis, affect oxygen uptake by blood)

Remarkability from parent implausibility

0.31
Rule weight: 0.42
Evidence weight: 0.96
Similarity weight: 0.78
Evidence: 0.77
Plausible(heart disease, cause high blood pressure)
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.29
¬ Plausible(beta blocker, increase blood sugar)
0.28
Rule weight: 0.42
Evidence weight: 0.85
Similarity weight: 0.78
Evidence: 0.25
Plausible(high blood pressure, become low blood pressure)
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.29
¬ Plausible(beta blocker, increase blood sugar)

Remarkability from sibling implausibility

0.44
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.86
Remarkable(cystic fibrosis, affect oxygen uptake by blood)
Evidence: 0.57
¬ Plausible(cystic fibrosis, affect oxygen uptake by blood)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.27
¬ Salient(beta blocker, increase blood sugar)

Similarity expansion

0.60
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.80
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.22
¬ Typical(beta blocker, increase potassium)
0.57
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.80
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.25
¬ Plausible(beta blocker, increase potassium)
0.55
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.82
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.37
¬ Typical(beta blocker, reduce blood pressure)
0.55
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.95
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.48
¬ Remarkable(beta blocker, lower blood sugar)
0.54
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.85
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.43
¬ Typical(beta blocker, decrease blood pressure)
0.53
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.80
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.31
¬ Salient(beta blocker, increase potassium)
0.48
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.82
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.43
¬ Plausible(beta blocker, reduce blood pressure)
0.47
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.78
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.51
¬ Typical(beta blocker, be used for high blood pressure)
0.47
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.85
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.49
¬ Plausible(beta blocker, decrease blood pressure)
0.45
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.95
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.78
¬ Typical(beta blocker, lower blood sugar)
0.42
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.95
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.68
¬ Plausible(beta blocker, lower blood sugar)
0.41
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.80
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.69
¬ Typical(beta blocker, lower blood pressure)
0.41
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.82
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.56
¬ Salient(beta blocker, reduce blood pressure)
0.40
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.80
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.61
¬ Remarkable(beta blocker, increase potassium)
0.40
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.95
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.69
¬ Salient(beta blocker, lower blood sugar)
0.39
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.78
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.59
¬ Plausible(beta blocker, be used for high blood pressure)
0.38
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.85
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.65
¬ Salient(beta blocker, decrease blood pressure)
0.37
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.80
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.68
¬ Remarkable(beta blocker, lower blood pressure)
0.36
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.80
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.67
¬ Plausible(beta blocker, lower blood pressure)
0.33
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.82
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.77
¬ Remarkable(beta blocker, reduce blood pressure)
0.33
Rule weight: 0.85
Evidence weight: 0.46
Similarity weight: 0.85
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.79
¬ Remarkable(beta blocker, decrease blood pressure)
0.30
Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.80
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.77
¬ Salient(beta blocker, lower blood pressure)
0.29
Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.78
¬ Salient(beta blocker, be used for high blood pressure)
0.29
Rule weight: 0.85
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.32
Remarkable(beta blocker, increase blood sugar)
Evidence: 0.83
¬ Remarkable(beta blocker, be used for high blood pressure)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.27
Salient(beta blocker, increase blood sugar)
Evidence: 0.43
¬ Typical(beta blocker, increase blood sugar)
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)

Typical implies Plausible

0.33
Rule weight: 0.48
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.29
Plausible(beta blocker, increase blood sugar)
Evidence: 0.43
¬ Typical(beta blocker, increase blood sugar)

Typicality and Rermarkability incompatibility between a parent and a child

0.39
Rule weight: 0.51
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.06
¬ Typical(high blood pressure, become low blood pressure)
0.29
Rule weight: 0.51
Evidence weight: 0.73
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.86
¬ Typical(heart disease, cause high blood pressure)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.85
Similarity weight: 0.78
Evidence: 0.32
¬ Remarkable(beta blocker, increase blood sugar)
Evidence: 0.47
¬ Typical(cystic fibrosis, affect oxygen uptake by blood)

Typicality inheritance from parent to child

0.37
Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 0.78
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.06
¬ Typical(high blood pressure, become low blood pressure)
0.19
Rule weight: 0.48
Evidence weight: 0.51
Similarity weight: 0.78
Evidence: 0.43
Typical(beta blocker, increase blood sugar)
Evidence: 0.86
¬ Typical(heart disease, cause high blood pressure)